All news

ARTL falls below Nasdaq $5M MVLS threshold

Alpha Vantage · TradingView · · AI-summarised by FinFlash

Artelo Biosciences (ARTL) has been flagged by Nasdaq for falling below the new $5M MVLS (Market Value of Listed Securities) threshold. The company is evaluating various options, including capital raises, warrant or securities actions, and expense management, to regain compliance. This rule change by Nasdaq is still subject to SEC review, with comments due by October 29, 2026.

Read original source

ARTL company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.